Skip to main content
Clinical Trials/ACTRN12621001327875
ACTRN12621001327875Not yet recruitingPhase 4

A prospective, randomised non-blinded pilot study to investigate the effect of oral tranexamic acid on the recovery time in patients undergoing primary total knee arthroplasty.

Wesley Medical Research0 sites80 target enrollmentStarted: September 29, 2021Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
50 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 1. Participants of either sex scheduled to undergo a primary, unilateral Total Knee Arthroplasty.
  • 2. Available for follow up at 6 months post-surgery.
  • 3. Willingness to provide written, informed consent.
  • 4. Willingness to comply with the study.

Exclusion Criteria

  • 1. Known allergy to TXA
  • 2, Acquired disturbances to colour vision
  • 3, Preoperative use of anticoagulants (within 5 days of surgery)
  • 4. Fibrinolytic disorders requiring intraoperative fibrinolytics
  • 5. Coagulopathy, history of arteriolar or venous thromboembolic disease
  • 6. Pregnancy or breastfeeding
  • 7. Haemoglobin <10g/dL

Investigators

Similar Trials